130 related articles for article (PubMed ID: 8007780)
1. Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma.
Schlemmer HP; Bachert P; Semmler W; Hohenberger P; Schlag P; Lorenz WJ; van Kaick G
Magn Reson Imaging; 1994; 12(3):497-511. PubMed ID: 8007780
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.
Kissel J; Brix G; Bellemann ME; Strauss LG; Dimitrakopoulou-Strauss A; Port R; Haberkorn U; Lorenz WJ
Cancer Res; 1997 Aug; 57(16):3415-23. PubMed ID: 9270007
[TBL] [Abstract][Full Text] [Related]
3. Selective 19F MR imaging of 5-fluorouracil and alpha-fluoro-beta-alanine.
Brix G; Bellemann ME; Zabel HJ; Bachert P; Lorenz WJ
Magn Reson Imaging; 1993; 11(8):1193-201. PubMed ID: 8271906
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic analysis of sparse in vivo NMR spectroscopy data using relative parameters and the population approach.
Port RE; Schlemmer HP; Bachert P
Eur J Clin Pharmacol; 1994; 47(2):187-93. PubMed ID: 7859808
[TBL] [Abstract][Full Text] [Related]
5. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.
van Laarhoven HW; Klomp DW; Rijpkema M; Kamm YL; Wagener DJ; Barentsz JO; Punt CJ; Heerschap A
NMR Biomed; 2007 Apr; 20(2):128-40. PubMed ID: 17006886
[TBL] [Abstract][Full Text] [Related]
6. 19F-magnetic resonance spectroscopy in patients with liver metastases of colorectal cancer treated with 5-fluorouracil.
Kamm YJ; Heerschap A; van den Bergh EJ; Wagener DJ
Anticancer Drugs; 2004 Mar; 15(3):229-33. PubMed ID: 15014355
[TBL] [Abstract][Full Text] [Related]
7. 19F-[1H] nuclear Overhauser effect and proton decoupling of 5-fluorouracil and alpha-fluoro-beta-alanine.
Krems B; Bachert P; Zabel HJ; Lorenz WJ
J Magn Reson B; 1995 Aug; 108(2):155-64. PubMed ID: 7648013
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis.
Rengelshausen J; Hull WE; Schwenger V; Göggelmann C; Walter-Sack I; Bommer J
Am J Kidney Dis; 2002 Feb; 39(2):E10. PubMed ID: 11840401
[TBL] [Abstract][Full Text] [Related]
9. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
[TBL] [Abstract][Full Text] [Related]
10. Mapping the biodistribution and catabolism of 5-fluorouracil in tumor-bearing rats by chemical-shift selective 19F MR imaging.
Brix G; Bellemann ME; Haberkorn U; Gerlach L; Bachert P; Lorenz WJ
Magn Reson Med; 1995 Sep; 34(3):302-7. PubMed ID: 7500866
[TBL] [Abstract][Full Text] [Related]
11. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.
Brix G; Bellemann ME; Haberkorn U; Gerlach L; Lorenz WJ
Nucl Med Biol; 1996 Oct; 23(7):897-906. PubMed ID: 8971857
[TBL] [Abstract][Full Text] [Related]
13. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy.
Semmler W; Bachert-Baumann P; Gückel F; Ermark F; Schlag P; Lorenz WJ; van Kaick G
Radiology; 1990 Jan; 174(1):141-5. PubMed ID: 2104675
[TBL] [Abstract][Full Text] [Related]
14. The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study.
Findlay MP; Leach MO; Cunningham D; Collins DJ; Payne GS; Glaholm J; Mansi JL; McCready VR
Ann Oncol; 1993 Aug; 4(7):597-602. PubMed ID: 8363990
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR
Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach.
Kissel J; Port RE; Zaers J; Bellemann ME; Strauss LG; Haberkorn U; Brix G
Med Phys; 1999 Apr; 26(4):609-15. PubMed ID: 10227363
[TBL] [Abstract][Full Text] [Related]
17. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
[TBL] [Abstract][Full Text] [Related]
18. Issues of normal tissue toxicity in patient and animal studies--effect of carbogen breathing in rats after 5-fluorouracil treatment.
Griffiths JR; McIntyre DJ; Howe FA; McSheehy PM; Ojugo ASE ; Rodrigues LM; Wadsworth P; Price NM; Lofts F; Nicholson G; Smid K; Noordhuis P; Peters GJ; Stubbs M
Acta Oncol; 2001; 40(5):609-14. PubMed ID: 11669333
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy.
Presant CA; Wolf W; Waluch V; Wiseman CL; Weitz I; Shani J
J Clin Oncol; 2000 Jan; 18(2):255-61. PubMed ID: 10637237
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 5-fluorouracil pharmacokinetics following intraperitoneal and intravenous administration using in vivo 19F magnetic resonance spectroscopy.
Glaholm J; Leach MO; Collins D; al Jehazi B; Sharp JC; Smith TA; Adach J; Hind A; McCready VR; White H
Br J Radiol; 1990 Jul; 63(751):547-53. PubMed ID: 2390689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
